Quarterly report pursuant to Section 13 or 15(d)

Note 15 - Stock-based Compensation and Other Benefit Plans - SAR Activity (Details)

v3.23.1
Note 15 - Stock-based Compensation and Other Benefit Plans - SAR Activity (Details) - Stock Appreciation Rights (SARs) [Member]
$ / shares in Units, shares in Thousands, $ in Thousands
 3 Months Ended
Mar. 31, 2023
USD ($)
$ / shares
shares
Outstanding, number of underlying shares (in shares) | shares 202
Outstanding, weighted average exercise price per share (in dollars per share) | $ / shares $ 1.87
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares) | shares 0
Granted, weighted average exercise price per share (in dollars per share) | $ / shares $ 0
Exercised, number of underlying shares (in shares) | shares (63)
Exercised, weighted average exercise price per share (in dollars per share) | $ / shares $ 0.86
Unvested SARs forfeited, number of underlying shares (in shares) | shares 0
Unvested SARs forfeited, weighted average exercise price per share (in dollars per share) | $ / shares $ 0
Vested SARs expired, number of underlying shares (in shares) | shares 0
Vested SARs expired, weighted average exercise price per share (in dollars per share) | $ / shares $ 0
Outstanding, number of underlying shares (in shares) | shares 139
Outstanding, weighted average exercise price per share (in dollars per share) | $ / shares $ 2.33
Outstanding, weighted average remaining contractual term (Year) 11 months 1 day
Outstanding, aggregate intrinsic value | $ $ 304
Exercisable, number of underlying shares (in shares) | shares 139
Exercisable, weighted average exercise price per share (in dollars per share) | $ / shares $ 2.33
Exercisable, weighted average remaining contractual term (Year) 11 months 1 day
Exercisable, aggregate intrinsic value | $ $ 304